Induced ACL Healing With the Ligamys Technique: a Prospective, Multicenter Observational Case Series
Ligamys
1 other identifier
observational
110
3 countries
3
Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of the Ligamys technique for the treatment of acute ruptures of the anterior cruciate ligament in a multicenter routine clinical setting. To conduct a long-term follow-up of the case series as a post-market product surveillance endeavor.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2013
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
July 28, 2014
CompletedFirst Posted
Study publicly available on registry
July 29, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2016
CompletedAugust 17, 2018
August 1, 2018
3.1 years
July 28, 2014
August 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Knee stability and function plus safety aspects
Knee stability: Lachman test Knee function: Lysholm score, IKDC score Safety: ACL re-ruptures or instabilities leading to an implant removal
12 months follow-up
Secondary Outcomes (1)
Patient satisfaction, work absence, activity, pain and secondary degenerative changes of the knee joint
10 years follow-up
Study Arms (1)
Ligamys
All patients treated with Ligamys can be included in the study. Patients must meet all of the inclusion criteria and none of the exclusion criteria to be enrolled.
Interventions
All patients are treated with Ligamys within 21 days after injury. The Ligamys implant has to be used in accordance with the instructions for use.
Eligibility Criteria
Patients with an acute rupture of the anterior cruciate ligament
You may qualify if:
- Primary rupture of the anterior cruciate ligament
- Signed patient informed consent
- Willingness to present for follow-up
- Injury - surgery time interval of 21 days or less
You may not qualify if:
- Medical non-compliance
- Unwillingness to follow the rehabilitation programme
- Traumatic cartilage lesion requiring cartilage repair procedure (Microfracturing, MACI, ACT) or degenerative cartilage lesions (Outerbridge \>ll and defect \>1cm2)
- Non-repairable meniscus lesions requiring a resection of \>20%
- Previous tendon removal on injured leg
- Relevant permanent medication (Steroids, cytostatic drugs, ...)
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
UZ Gent
Ghent, 9000, Belgium
Universitätsklinikum Münster
Münster, 48149, Germany
Sonnenhof
Bern, 3008, Switzerland
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stefan Eggli, Prof Dr med
Klinik Sonnenhof, Switzerland
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 28, 2014
First Posted
July 29, 2014
Study Start
August 1, 2013
Primary Completion
September 1, 2016
Study Completion
September 1, 2016
Last Updated
August 17, 2018
Record last verified: 2018-08